Stock PSG PHARMASGP HOLDING SE
Add to a list
To use this feature you must be a member
Log inSign up

News PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Real-time Estimate Tradegate
Other stock markets
 09:18:31 2024-04-25 am EDT 		5-day change 1st Jan Change
22 EUR -0.90% Intraday chart for PharmaSGP Holding SE 0.00% -2.22%
Apr. 18 PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 CI
Apr. 18 PharmaSGP Holding SE Announces Changes to Dividend Policy CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
EQ
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023
CI
PharmaSGP Holding SE Announces Changes to Dividend Policy
CI
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.
CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023
CI
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
PharmaSGP achieves top performance in the first half of 2023
EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
PharmaSGP Completes EUR2 Million Share Buyback Program
MT
CMS: PharmaSGP Holding SE completes Share Buy-Back Program
EQ
CMS: PharmaSGP Holding SE: Release of a capital market information
EQ
CMS: PharmaSGP Holding SE: Release of a capital market information
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSG Stock
  4. News PharmaSGP Holding SE